Harmony Biosciences Acquires US Rights to Narcolepsy Drug That Is Currently Available in Europe


McDermott Paris and US corporate and antitrust lawyers were counsel to French company Bioprojet SCR in structuring a collaborative agreement that gave biopharmaceutical company Harmony Biosciences the exclusive US right to develop, register and market a drug to treat adults suffering from narcolepsy.